|
|
||||||||
Clinical Chemistry, Vol 35, 2070-2073, Copyright © 1989 by American Association for Clinical Chemistry
IF McDowell, GB Wisdom and ER Trimble
Department of Clinical Biochemistry, Royal Victoria Hospital, Belfast, U.K.
Polymorphism at the apolipoprotein E (ApoE) locus is an important factor in the development of remnant (Type III) hyperlipidemia and also influences the distribution of cholesterol concentrations in the population. The new method for ApoE phenotyping described here gives good results with simple apparatus. Serum (10 microL) is digested with sialidase (EC 3.2.1.18), delipidated, and redissolved in 6 mol/L urea. Electrofocusing is carried out in agarose, followed by immunoblotting with a monoclonal antibody to ApoE and an anti-immunoglobulin- peroxidase conjugate. Sialidase-catalyzed digestion effectively removes sialated forms of ApoE, which eases interpretation. This method can be used in nonspecialist laboratories and is particularly suited for assay of large numbers of samples.
The following articles in journals at HighWire Press have cited this article:
![]() |
P. A. C. McPherson, I. S. Young, B. McKibben, and J. McEneny High density lipoprotein subfractions: isolation, composition, and their duplicitous role in oxidation J. Lipid Res., January 1, 2007; 48(1): 86 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Albrecht, J. H. McVey, J. I. Elliott, A. Sardini, I. Kasza, A. D. Mumford, R. P. Naoumova, E. G. D. Tuddenham, K. Szabo, and C. F. Higgins A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome Blood, July 15, 2005; 106(2): 542 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. O'Neill, D. D. Patel, B. L. Knight, C. K. Y. Neuwirth, M. Bourbon, A. K. Soutar, G. W. Taylor, G. R. Thompson, and R. P. Naoumova Determinants of Variable Response to Statin Treatment in Patients With Refractory Familial Hypercholesterolemia Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 832 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hock, K. Heese, F. Muller-Spahn, P. Huber, W. Riesen, R. M. Nitsch, and U. Otten Increased CSF levels of nerve growth factor in patients with Alzheimer's disease Neurology, May 23, 2000; 54(10): 2009 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Bolla, N. Wood, and S. E. Humphries Rapid determination of apolipoprotein E genotype using a heteroduplex generator J. Lipid Res., December 1, 1999; 40(12): 2340 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Hunninghake, E. A. Stein, C. A. Dujovne, W. S. Harris, E. B. Feldman, V. T. Miller, J. A. Tobert, P. M. Laskarzewski, E. Quiter, J. Held, et al. The Efficacy of Intensive Dietary Therapy Alone or Combined with Lovastatin in Outpatients with Hypercholesterolemia N. Engl. J. Med., April 29, 1993; 328(17): 1213 - 1219. [Abstract] [Full Text] |
||||
![]() |
A. D. Tagalakis, I. R. Graham, D. R. Riddell, J. G. Dickson, and J. S. Owen Gene Correction of the Apolipoprotein (Apo) E2 Phenotype to Wild-type ApoE3 by in Situ Chimeraplasty J. Biol. Chem., April 13, 2001; 276(16): 13226 - 13230. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |